TOLNAFTATE- antifungal spray liquid aerosol, spray 
Chain Drug Consortium, LLC

----------

Premier Value Antifungal Spray Liquid

Active ingredient

Tolnaftate 1%

Purpose

Antifungal

Uses

Warnings

For external use only.

​Flammable:

Do not use while smoking or near heat or flame. Do not puncture or incinerate. Contents under pressure. Do not store at temperature above 120ºF. Intentional misuse by deliberately concentrating and inhaling contents can be harmful or fatal.

When using this product

  • avoid contact with the eyes or mouth
  • use only as directed

​Stop use and ask a doctor if

  • irritation occurs
  • no improvement within 4 weeks

​Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

​Directions

​Other information

store between 20º and 30ºC (68º and 86ºF)

​Inactive ingredients

BHT, isobutane, PPG-12-buteth-16, SD alcohol 40-B

​Questions?

Call 1-866-964-0939

​Principal Display Panel

​Premier Value

Antifungal

Athlete's Foot

Liquid Spray

Tolnaftate 1%

Cures most athlete's foot and prevents recurrences

Relieves itching, cracking and burning

Net WT 5.3 OZ (150g)

tolnaftate liquid spray

TOLNAFTATE 
antifungal spray liquid aerosol, spray
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-609
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TOLNAFTATE (UNII: 06KB629TKV) (TOLNAFTATE - UNII:06KB629TKV) TOLNAFTATE0.15 g  in 150 g
Inactive Ingredients
Ingredient NameStrength
ALCOHOL (UNII: 3K9958V90M)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
ISOBUTANE (UNII: BXR49TP611)  
PPG-12-BUTETH-16 (UNII: 58CG7042J1)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-609-00150 g in 1 CAN; Type 0: Not a Combination Product05/23/2003
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM00505/23/2003
Labeler - Chain Drug Consortium, LLC (101668460)

Revised: 2/2024
Document Id: 106ae2d7-816a-bcc1-e063-6294a90ad903
Set id: 4bc5b883-23e6-41a0-a2f6-3eb6100dd48d
Version: 7
Effective Time: 20240202
 
Chain Drug Consortium, LLC